Spontaneous Emergence of Cefiderocol Resistance in Klebsiella pneumoniae KPC-163: Genomic and Transcriptomic Insights
<b>Background/Objectives:</b> Carbapenem-resistant <i>Klebsiella pneumoniae</i> (CRKP) is an urgent public health threat due to its rapid dissemination and resistance to last-line antibiotics. Cefiderocol (FDC), a novel siderophore cephalosporin, targets resistant Gram-negative pathogens by exploiting bacterial iron uptake mechanisms. However, resistance to FDC is emerging among <i>Klebsiella pneumoniae</i> carbapenemase (KPC)-producing <i>K. pneumoniae</i> strains. This study characterizes a spontaneous FDC-resistant subpopulation (IHC216) derived from a KPC-producing strain (KPNMA216) using comprehensive genomic, transcriptional, and phenotypic analyses. <b>Methods</b>: Given the whole-genome sequencing results, where mutations were identified in genes involved in transcriptional regulation and membrane permeability (<i>ompC</i>) among others, in the present work we further explore their potential implications and conduct a more detailed analysis of the IHC216 genome. A qRT-PCR analysis highlighted significant downregulation of classical siderophore-mediated iron acquisition systems (<i>fepA</i>, <i>cirA</i>, <i>iroN</i>) and upregulation of alternative iron uptake pathways (<i>iucA</i>, <i>fiU</i>), reflecting a switch in iron acquisition strategies. <b>Results</b>: A notable downregulation of <i>bla</i><sub>KPC-163</sub> correlated with restored susceptibility to carbapenems, indicating collateral susceptibility. Altered expressions of <i>pbp2</i> and <i>pbp3</i> implicated adaptive changes in cell wall synthesis, potentially affecting FDC resistance mechanisms. Furthermore, enhanced oxidative stress responses via upregulated <i>sodC</i> expression and increased capsule production were observed. <b>Conclusions</b>: These findings underscore the complex interplay of genetic and transcriptional adaptations underlying FDC resistance, highlighting potential therapeutic vulnerabilities.
Authors
- Robert A. Bonomo (ORCID: https://orcid.org/0000-0002-3299-894X)
- Marcelo E. Tolmasky (ORCID: https://orcid.org/0000-0002-6298-7811)
- Fernando Pasterán (ORCID: https://orcid.org/0000-0001-5840-5869)
- Quentin Vallé (ORCID: https://orcid.org/0000-0002-1525-9993)
- Germán M. Traglia (ORCID: https://orcid.org/0000-0002-4780-5311)
- Vyanka Mezcord (ORCID: https://orcid.org/0000-0003-1896-8450)
- Jenny Escalante
- Marisel R. Tuttobene (ORCID: https://orcid.org/0000-0003-0234-4643)
- Gauri G. Rao (ORCID: https://orcid.org/0000-0002-8704-7770)
- María Soledad Ramírez (ORCID: https://orcid.org/0000-0002-9904-7890)
- Chuanle Cheng (ORCID: https://orcid.org/0000-0002-4645-8928)
- María Cecilia Rodríguez (ORCID: https://orcid.org/0000-0002-2598-9746)
- Rajnikant Sharma (ORCID: https://orcid.org/0000-0002-0891-7548)
- Irene Luu (ORCID: https://orcid.org/0009-0007-6890-3619)
Institutions
- University of Southern California (US)
- California State University, Fullerton (US)
- Consejo Nacional de Investigaciones Científicas y Técnicas (AR)
- Universidad de la República de Uruguay (UY)
- National University of Rosario (AR)
- Geriatric Research Education and Clinical Center (US)
- Louis Stokes Cleveland VA Medical Center (US)
- Administración Nacional de Laboratorios e Institutos de Salud (AR)
- Centro Científico Tecnológico - Tucumán (AR)
- Instituto de Biología Molecular y Celular de Rosario (AR)
- University School (US)
- Case Western Reserve University (US)
Publication Details
- Journal
- Antibiotics
- Published
- 2025-08-15
- DOI
- https://doi.org/10.3390/antibiotics14080832
- Citations
- 1
- Primary Topic
- Antibiotic Resistance in Bacteria
- Type
- article
- Field-Weighted Citation Impact
- 0.59
Funders
- U.S. Department of Veterans Affairs
- National Institutes of Health